Suchergebnisse - "Krytska, Kateryna"

PubPharm (25)

1

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

enthalten in: bioRxiv.org | 2024

von Weiner, A. | Radaoui, A. | Tsang, M. | +33

2

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

enthalten in: bioRxiv : the preprint server for biology | 2024

von Weiner, A. | Radaoui, A. | Tsang, M. | +33

3

Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma

enthalten in: Nature communications | 2023

von Berko, E. | Witek, G. | Matkar, S. | +19

4

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma : phase 1 trial results

enthalten in: Nature medicine | 2023

von Goldsmith, K. | Park, J. | Kayser, K. | +32

5

Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma

enthalten in: Cancer research communications | 2022

von Krytska, K. | Casey, C. | Pogoriler, J. | +14

6

Venetoclax-based Rational Combinations are Effective in Models of MYCN-amplified Neuroblastoma

enthalten in: Molecular cancer therapeutics | 2021

von Dalton, K. | Krytska, K. | Lochmann, T. | +16

7

The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Kendsersky, N. | Lindsay, J. | Kolb, E. | +20

8

Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design

enthalten in: bioRxiv.org | 2020

von Rokita, J. | Rathi, K. | Cardenas, M. | +64

9

Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

enthalten in: Cell reports | 2019

von Rokita, J. | Rathi, K. | Cardenas, M. | +66

10

Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Lowery, C. | Dowless, M. | Renschler, M. | +21